$28.10-3.77%
2026-10-05 closeLoading chart…
Today's signals · No active technical signal.
Signal details →Quince Therapeutics last closed at $28.10 (-3.77%) on 2026-10-05. Listed on Nasdaq. Trailing 12 months PER is -1.9×. Its overall grade ranks 527 of 741 stocks in Healthcare.
About this company
Quince Therapeutics last closed at $28.10 (-3.77%) on 2026-10-05. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall C · 527/741
Valuation grade B-
Related stocks
- BioMarin PharmaceuticalCompetitor
희귀질환·소아 신경계 질환 치료제 개발/상업화에서 비교되는 바이오제약사
- Ultragenyx PharmaceuticalCompetitor
희귀질환 치료제 중심의 경쟁 바이오텍으로 파이프라인·상업화 측면에서 유사
- Sarepta TherapeuticsCompetitor
희귀 유전질환 치료 분야에서 투자자들이 함께 비교하는 대표 경쟁사
About Quince Therapeutics
- What technical signals does Quince Therapeutics (QNCX) have?
- Quince Therapeutics current technical signals: no active technical signal.
- Is Quince Therapeutics a cup-and-handle pattern?
- No. Quince Therapeutics has no valid Cup signal right now.
- What published figures are available for Quince Therapeutics?
- Market cap: $7.82M. Trailing 12 months PER: -1.9×. Latest quarter PBR: 1.59×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Quince Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy